文献速递乳腺癌

乳腺癌的研究需求

Research needs in breast cancer.
PubMed 文献 · Ann Oncol · 2017-01-01

本文总结了2016年专家小组确定的乳腺癌12项中短期临床研究优先需求,旨在聚焦并加速最急需领域的研究,涵盖早期乳腺癌治疗降阶梯、辅助治疗时长、遗传易感性识别、年轻患者管理、生物标志物药物开发、耐药靶点、转移灶局部治疗、治疗顺序、瘤内异质性、三阴性乳腺癌生物学、免疫监测与免疫治疗及生存者研究。

要点

  • 早期乳腺癌治疗降阶梯需在不牺牲疗效的前提下进行。
  • 需识别和验证介导化疗、内分泌治疗和抗HER2治疗耐药的靶点。
  • 需加强生存者研究,包括支持治疗和生活质量。

核心结论

  • 尽管乳腺癌研究在某些领域取得显著进展,但其他领域未同等受益,知识仍存在许多空白。
  • 本文总结的12项中短期临床研究需求被专家小组视为2016年的优先事项。

研究设计与样本

  • 本文为专家小组总结的2016年乳腺癌中短期临床研究优先需求。

主要发现

  • 优先需求包括:在不牺牲疗效的前提下对早期乳腺癌治疗进行降阶梯。
  • 探索最佳辅助治疗时长。
  • 开发更好的工具和策略以识别遗传易感患者。
  • 改善年轻乳腺癌患者的护理。
  • 开发工具以加速生物标志物定义人群中的药物开发。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

New research questions emerge as medical needs continue to evolve and as we improve our understanding of cancer biology and treatment of malignancies. Although significant advances have been made in some areas of breast cancer research resulting in improvements in therapies and outcomes over the last few decades, other areas have not benefited to the same degree and we continue to have many gaps in our knowledge. This article summarizes the 12 short and medium-term clinical research needs in breast cancer deemed as priorities in 2016 by a panel of experts, in an attempt to focus and accelerate future research in the most needed areas: (i) de-escalate breast cancer therapies in early breast cancer without sacrificing outcomes; (ii) explore optimal adjuvant treatment durations; (iii) develop better tools and strategies to identify patients with genetic predisposition; (iv) improve care in young patients with breast cancer; (v) develop tools to speed up drug development in biomarker-defined populations; (vi) identify and validate targets that mediate resistance to chemotherapy, endocrine therapy and anti-HER2 therapies; (vii) evaluate the efficacy of local-regional treatments for metastatic disease; (viii) better define the optimal sequence of treatments in the metastatic setting; (ix) evaluate the clinical impact of intra-patient heterogeneity (intra-tumor, inter-tumor and inter-lesion heterogeneity); (x) better understand the biology and identify new targets in triple-negative breast cancer; (xi) better understand immune surveillance in breast cancer and further develop immunotherapies; and (xii) increase survivorship research efforts including supportive care and quality of life.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Cardoso F, Harbeck N, Barrios CH, et al. Research needs in breast cancer. Ann Oncol. 2017. PMID: 27831505. doi:10.1093/annonc/mdw571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。